Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Generic Injectable Market, by Region, 2018-2027 (USD Billion)
1.2.2. Generic Injectable Market, by Product Type, 2018-2027 (USD Billion)
1.2.3. Generic Injectable Market, by Molecule Type, 2018-2027 (USD Billion)
1.2.4. Generic Injectable Market, by Application, 2018-2027 (USD Billion)
1.2.5. Generic Injectable Market, by Route of Administration, 2018-2027 (USD Billion)
1.2.6. Generic Injectable Market, by Distribution Channel, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Generic Injectable Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Generic Injectable Market Dynamics
3.1. Generic Injectable Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of chronic diseases
3.1.1.2. The expiration of branded item patents and a decrease in the number of new product releases
3.1.2. Market Challenges
3.1.2.1. Complex manufacturing of generic injectables
3.1.2.2. Rising stringent regulation
3.1.3. Market Opportunities
3.1.3.1. Expansion of large molecule products into injectables
3.1.3.2. Investments on manufacturing capabilities by emerging countries
Chapter 4. Global Generic Injectable Market Industry Analysis
4.1. Porters 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porters 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Generic Injectable Market, by Product Type
5.1. Market Snapshot
5.2. Global Generic Injectable Market by Product Type, Performance - Potential Analysis
5.3. Global Generic Injectable Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Generic Injectable Market, Sub Segment Analysis
5.4.1. Monoclonal Antibodies
5.4.2. Immunoglobulin Generic injectable
5.4.3. Insulin Generic injectable
5.4.4. Blood Factors Generic injectable
5.4.5. Peptide Antibiotics Generic injectable
5.4.6. Vaccines Generic injectable
5.4.7. Chemotherapy Agents Generic injectable
5.4.8. Others
Chapter 6. Global Generic Injectable Market, by Molecule Type
6.1. Market Snapshot
6.2. Global Generic Injectable Market by Molecule Type, Performance - Potential Analysis
6.3. Global Generic Injectable Market Estimates & Forecasts by Molecule Type 2017-2027 (USD Billion)
6.4. Generic Injectable Market, Sub Segment Analysis
6.4.1. Small Molecule Generic injectable
6.4.2. Large Molecule Generic injectable
Chapter 7. Global Generic Injectable Market, by Application
7.1. Market Snapshot
7.2. Global Generic Injectable Market by Application, Performance - Potential Analysis
7.3. Global Generic Injectable Market Estimates & Forecasts by Application 2017-2027 (USD Billion)
7.4. Generic Injectable Market, Sub Segment Analysis
7.4.1. Oncology
7.4.2. Infectious Diseases
7.4.3. Diabetes
7.4.4. Blood Disorders
7.4.5. CNS Diseases
7.4.6. Cardiovascular Diseases
7.4.7. Others
Chapter 8. Global Generic Injectable Market, by Route of Administration
8.1. Market Snapshot
8.2. Global Generic Injectable Market by Route of Administration, Performance - Potential Analysis
8.3. Global Generic Injectable Market Estimates & Forecasts by Route of Administration 2017-2027 (USD Billion)
8.4. Generic Injectable Market, Sub Segment Analysis
8.4.1. Intravenous (IV) Generic injectable
8.4.2. Intramuscular (IM) Generic injectable
8.4.3. Subcutaneous (SC) Generic injectable
Chapter 9. Global Generic Injectable Market, by Distribution Channel
9.1. Market Snapshot
9.2. Global Generic Injectable Market by Distribution Channel, Performance - Potential Analysis
9.3. Global Generic Injectable Market Estimates & Forecasts by Distribution Channel 2017-2027 (USD Billion)
9.4. Generic Injectable Market, Sub Segment Analysis
9.4.1. Hospital Pharmacies
9.4.2. Retail Pharmacies
9.4.3. Drug Stores
9.4.4. Online Pharmacies
Chapter 10. Global Generic Injectable Market, Regional Analysis
10.1. Generic Injectable Market, Regional Market Snapshot
10.2. North America Generic Injectable Market
10.2.1. U.S. Generic Injectable Market
10.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027
10.2.1.2. Molecule Type breakdown estimates & forecasts, 2017-2027
10.2.1.3. Application breakdown estimates & forecasts, 2017-2027
10.2.1.4. Route of Administration breakdown estimates & forecasts, 2017-2027
10.2.1.5. Distribution Channel breakdown estimates & forecasts, 2017-2027
10.2.2. Canada Generic Injectable Market
10.3. Europe Generic Injectable Market Snapshot
10.3.1. U.K. Generic Injectable Market
10.3.2. Germany Generic Injectable Market
10.3.3. France Generic Injectable Market
10.3.4. Spain Generic Injectable Market
10.3.5. Italy Generic Injectable Market
10.3.6. Rest of Europe Generic Injectable Market
10.4. Asia-Pacific Generic Injectable Market Snapshot
10.4.1. China Generic Injectable Market
10.4.2. India Generic Injectable Market
10.4.3. Japan Generic Injectable Market
10.4.4. Australia Generic Injectable Market
10.4.5. South Korea Generic Injectable Market
10.4.6. Rest of Asia Pacific Generic Injectable Market
10.5. Latin America Generic Injectable Market Snapshot
10.5.1. Brazil Generic Injectable Market
10.5.2. Mexico Generic Injectable Market
10.6. Rest of The World Generic Injectable Market

Chapter 11. Competitive Intelligence
11.1. Top Market Strategies
11.2. Company Profiles
11.2.1. Samsung Biologics Co Ltd
11.2.1.1. Key Information
11.2.1.2. Overview
11.2.1.3. Financial (Subject to Data Availability)
11.2.1.4. Product Summary
11.2.1.5. Recent Developments
11.2.2. Aurobindo Pharma Limited
11.2.3. Sun Pharmaceutical Industries Ltd.
11.2.4. Novartis AG
11.2.5. Merck & Co. Inc.
11.2.6. Cipla Ltd
11.2.7. Pfizer Inc
11.2.8. Fresenius Kabi
11.2.9. Sanofi S.A
11.2.10. AstraZeneca Plc
Chapter 12. Research Process
12.1. Research Process
12.1.1. Data Mining
12.1.2. Analysis
12.1.3. Market Estimation
12.1.4. Validation
12.1.5. Publishing
12.2. Research Attributes
12.3. Research Assumption